The Antiviral Effect of Nirmatrelvir/Ritonavir during COVID-19 Pandemic Real-World Data.

Vasilios Petrakis,Petros Rafailidis,Grigorios Trypsianis,Dimitrios Papazoglou,Periklis Panagopoulos

Viruses（2023）

引用 3|浏览2

暂无评分

摘要

Oral treatment with nirmatrelvir/ritonavir in high-risk non-hospitalized patients was safe and effective in preventing the severe clinical progress of COVID-19 pneumonia. Early administration of antiviral agents in vulnerable outpatients combined with a full vaccination scheme is significant in order to avoid hospitalization and severe clinical outcomes.

查看译文

关键词

COVID-19,Omicron variants,SARS-CoV-2,antiviral treatment,nirmatrelvir/ritonavir

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要